I think the CVS dropout last July, which Amarin probably learned about while they were trying to get approval for the share buyback, spoiled the plans for a buyback. The company probably has to worry that one of the other pillars of its exclusive sales deals in the U.S. could vanish just as quickly as CVS did. If so, the "nearly $300 million" in its cash pile could start shrinking at a rapid rate. So I think the company acted sensibly in keeping its cash and doing the reverse stock split, as much as I hate that my 50,000 shares will now be about 1,500. The 1-for-20 split also seems consistent with what other companies do. If the goal is to keep the share price above $5, a 1-for-10 split would be cutting it too close.